FindTrial
Sign In

REACH: Researching Variables Associated with Non-adherence to Psychotropic Medications in Severe Mental Illnesses Leading to Hospitalization

A study on factors associated with psychotropic medication non-adherence among persons with severe mental illness experiencing relapse and necessitating inpatient care at a tertiary psychiatric center - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/066463
Enrollment
150
Registered
2024-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F311- Bipolar disorder, current episodemanic without psychotic features Health Condition 2: F332- Major depressive disorder, recurrent severe without psychotic features Health Condition 3: F200- Paranoid schizophrenia

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

National Institute of Mental Health and Neurosciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants above the age of 18 years 2. The participant has been admitted with relapse or exacerbation of an illness. 3. Medication non-adherence – Individuals who have completely stopped their therapeutic medications (antipsychotics, antidepressants, and mood stabilizers) for more than or equal to one week since requiring inpatient care. 4. Participants/family caregivers providing informed consent.

Exclusion criteria

Exclusion criteria: Patients experiencing relapse of symptoms due to factors other than non-adherence e.g., first episode of severe mental illness, break through episode or is strictly due to substance use.

Design outcomes

Primary

MeasureTime frame
BPRS scale will be used to assess baseline severity of psychopathology following which SOFIA scale will be applied to assess reason for medication nonadherence. OUTCOMES To assess the factors associated with non-adherence to psychotropic medication. To assess if a specific disorder or class of psychotropic medication is disproportionately high in association with non-adherence. Timepoint: No intermediate time points in this trial. Data and outcome will be assessed after completion of interviewing 150 patients. After the complete data is available estimated after 1 year - data/outcome it will be assessed—

Secondary

MeasureTime frame
To assess if a specific disorder or class of psychotropic medication is disproportionately high in association with non-adherence. Timepoint: No pre-specified time points. Data will be analyzed after completion of interviewing 150 patients. After the complete data is available estimated after 1 year - data/outcome it will be assessed—

Countries

India

Contacts

Public ContactDr Shah Daivik Rupeshkumar

National Institute of Mental Health And Neurosciences

drbsnake@gmail.com9686976128

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026